跳至主要内容
临床试验/CTRI/2009/091/000050
CTRI/2009/091/000050已完成3 期

A Safety and Efficacy Trial Evaluating the Use of Apixaban for the Extended Treatment of Deep Vein Thrombosis and Pulmonary Embolism

This trial is being sponsored by BristolMyers Squibb0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Men and women ≥ 18 years of age;
  • Clinical diagnosis of DVT or PE;
  • Anticoagulant treatment completed
  • No recurrence of VTE

排除标准

  • Subjects with indications for long-term treatment with a vitamin K antagonist
  • Active bleeding or high risk for serious bleeding
  • Short life expectancy
  • Uncontrolled high blood pressure
  • Impaired kidney or liver function

研究者

发起方
This trial is being sponsored by BristolMyers Squibb

相似试验

进行中(未招募)
不适用
A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism - ND
EUCTR2007-007867-25-ITBRISTOL-M.SQUIBB4,816
进行中(未招募)
不适用
A safety and Efficacy Trial Evaluating the Use of Apixaban in theTreatment of Symptomatic Deep Vein Thrombosis and PulmonaryEmbolismVenous Thromboembolism (VTE)MedDRA version: 14.1Level: PTClassification code 10037377Term: Pulmonary embolismSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: PTClassification code 10051055Term: Deep vein thrombosisSystem Organ Class: 10047065 - Vascular disorders
EUCTR2007-007867-25-DKBristol-Myers Squibb International Corporation5,400
进行中(未招募)
不适用
A safety and Efficacy Trial Evaluating the Use of Apixaban in theTreatment of Symptomatic Deep Vein Thrombosis and PulmonaryEmbolism
EUCTR2007-007867-25-CZBristol-Meyers Squibb International Corporation5,400
进行中(未招募)
不适用
A safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary EmbolismVenous Thromboembolism (VTE)MedDRA version: 14.1Level: PTClassification code 10037377Term: Pulmonary embolismSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: PTClassification code 10051055Term: Deep vein thrombosisSystem Organ Class: 10047065 - Vascular disorders
EUCTR2007-007867-25-DEBristol-Myers Squibb International Corporation5,400
进行中(未招募)
不适用
A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary EmbolismRevised Protocol Number: 01, Incorporates amendment(s) 02+ Protocol Amendment 01 (version 1.0 dated 21-Apr-08) Site-specific - Molecular Profiling Supplement Samples For Pfizer’s Exploratory Research BiobankVenous Thromboembolism (VTE)MedDRA version: 9.1Level: PTClassification code 10051055Term: Deep vein thrombosisMedDRA version: 9.1Level: PTClassification code 10037377Term: Pulmonary embolism
EUCTR2007-007867-25-PTBristol-Meyers Squibb International Corporation4,816